Topical liposomal system for localized and controlled drug delivery

Area of Science:

• Pharmaceutics
• Drug Delivery Systems
• Nanotechnology

Background:

• Topical delivery of local anesthetics like benzocaine often faces challenges with rapid release and short duration of action.
• Liposomes offer potential for controlled and localized drug delivery, improving therapeutic efficacy and patient compliance.

Purpose of the Study:

• To develop and characterize liposomal reservoir systems for controlled topical delivery of benzocaine.
• To evaluate the in vitro and in vivo performance of benzocaine-loaded liposomes in ointment and gel formulations.
• To investigate the potential of ultrasound for modulating drug release from liposomal depots.

Main Methods:

• Benzocaine was encapsulated in liposomes, which were then incorporated into ointment and gel bases.
• In vitro drug release studies were conducted over 24 hours.
• Drug permeation across human cadaver skin was assessed.
• In vivo studies evaluated the duration of action.
• Ultrasound was applied to study pulsatile drug delivery.

Main Results:

• Liposomal systems demonstrated controlled drug release over 24 hours, contrasting with the rapid release (>92%) from plain benzocaine ointment.
• Drug delivery through human cadaver skin was significantly slower with liposomal formulations.
• In vivo studies confirmed a longer duration of action for liposomal formulations.
• Apparent zero-order kinetics were observed for drug release from liposomes.

Conclusions:

• Liposomes serve as effective slow-release vehicles for topical benzocaine delivery, exhibiting apparent zero-order kinetics.
• Liposomal formulations enhance the duration of action for topical anesthetics.
• The study highlights the potential of liposomes and ultrasound in modulating topical drug input via the skin.